Joincare Pharmaceutical Group Industry Co Ltd (SHG:600380) — Market Cap & Net Worth
Market Cap & Net Worth: Joincare Pharmaceutical Group Industry Co Ltd (600380)
Joincare Pharmaceutical Group Industry Co Ltd (SHG:600380) has a market capitalization of $2.90 Billion (CN¥19.83 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #5079 globally and #992 in its home market, demonstrating a -0.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Joincare Pharmaceutical Group Industry Co Ltd's stock price CN¥10.84 by its total outstanding shares 1829453386 (1.83 Billion). Analyse 600380 cash flow metrics to see how efficiently the company converts income to cash.
Joincare Pharmaceutical Group Industry Co Ltd Market Cap History: 2015 to 2026
Joincare Pharmaceutical Group Industry Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $2.99 Billion to $2.90 Billion (0.28% CAGR).
Index Memberships
Joincare Pharmaceutical Group Industry Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Shanghai Shenzhen CSI 300
CSI300
|
$4.20 Trillion | 0.07% | #189 of 285 |
Weight: Joincare Pharmaceutical Group Industry Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Joincare Pharmaceutical Group Industry Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Joincare Pharmaceutical Group Industry Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.19x
Joincare Pharmaceutical Group Industry Co Ltd's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.18x
Joincare Pharmaceutical Group Industry Co Ltd's market cap is 2.18 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.99 Billion | $8.64 Billion | $412.47 Million | 0.35x | 7.26x |
| 2016 | $2.17 Billion | $9.72 Billion | $451.42 Million | 0.22x | 4.82x |
| 2017 | $2.49 Billion | $10.78 Billion | $2.13 Billion | 0.23x | 1.17x |
| 2018 | $1.67 Billion | $11.20 Billion | $699.41 Million | 0.15x | 2.38x |
| 2019 | $2.64 Billion | $11.98 Billion | $894.35 Million | 0.22x | 2.95x |
| 2020 | $3.58 Billion | $13.52 Billion | $1.12 Billion | 0.27x | 3.20x |
| 2021 | $3.34 Billion | $15.90 Billion | $1.33 Billion | 0.21x | 2.52x |
| 2022 | $2.98 Billion | $17.14 Billion | $1.50 Billion | 0.17x | 1.98x |
| 2023 | $3.33 Billion | $16.65 Billion | $1.44 Billion | 0.20x | 2.31x |
| 2024 | $3.02 Billion | $15.62 Billion | $1.39 Billion | 0.19x | 2.18x |
Competitor Companies of 600380 by Market Capitalization
Companies near Joincare Pharmaceutical Group Industry Co Ltd in the global market cap rankings as of May 7, 2026.
Key companies related to Joincare Pharmaceutical Group Industry Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #501 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #530 globally with a market cap of $50.06 Billion USD ( CN¥342.11 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #541 globally with a market cap of $49.01 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #574 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #501 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.06 Billion | CN¥53.63 |
| #541 | Zoetis Inc | NYSE:ZTS | $49.01 Billion | $111.22 |
| #574 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $43.83 |
Joincare Pharmaceutical Group Industry Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Joincare Pharmaceutical Group Industry Co Ltd's market cap moved from $2.99 Billion to $ 2.90 Billion, with a yearly change of 0.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.90 Billion | -6.15% |
| 2025 | CN¥3.09 Billion | +2.48% |
| 2024 | CN¥3.02 Billion | -9.33% |
| 2023 | CN¥3.33 Billion | +11.74% |
| 2022 | CN¥2.98 Billion | -10.95% |
| 2021 | CN¥3.34 Billion | -6.71% |
| 2020 | CN¥3.58 Billion | +35.81% |
| 2019 | CN¥2.64 Billion | +58.35% |
| 2018 | CN¥1.67 Billion | -33.12% |
| 2017 | CN¥2.49 Billion | +14.64% |
| 2016 | CN¥2.17 Billion | -27.38% |
| 2015 | CN¥2.99 Billion | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Joincare Pharmaceutical Group Industry Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.90 Billion USD |
| MoneyControl | $2.90 Billion USD |
| MarketWatch | $2.90 Billion USD |
| marketcap.company | $2.90 Billion USD |
| Reuters | $2.90 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medic… Read more